Febuxostat Patent Expiration
Febuxostat is Used for managing hyperuricemia in patients with gout. It was first introduced by Takeda Pharmaceuticals Usa Inc
Febuxostat Patents
Given below is the list of patents protecting Febuxostat, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Uloric | US8372872 | Methods for concomitant treatment of theophylline and febuxostat | Sep 08, 2031 | Takeda Pharms Usa |
| Uloric | US9107912 | Methods for concomitant treatment of theophylline and febuxostat | Sep 08, 2031 | Takeda Pharms Usa |
| Uloric | US7361676 | Solid preparation containing single crystal form |
Mar 08, 2024
(Expired) | Takeda Pharms Usa |
| Uloric | US6225474 | Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same |
Jun 18, 2019
(Expired) | Takeda Pharms Usa |
| Uloric | US5614520 | 2-arylthiazole derivatives and pharmaceutical composition thereof |
Mar 25, 2019
(Expired) | Takeda Pharms Usa |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Febuxostat's patents.
Latest Legal Activities on Febuxostat's Patents
Given below is the list recent legal activities going on the following patents of Febuxostat.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Feb, 2023 | US9107912 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 12 Aug, 2020 | US8372872 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 01 Oct, 2019 | US7361676(Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 18 Feb, 2019 | US9107912 |
| Change in Power of Attorney (May Include Associate POA) Critical | 30 Jan, 2019 | US9107912 |
| Email Notification Critical | 30 Jan, 2019 | US9107912 |
| Correspondence Address Change Critical | 29 Jan, 2019 | US9107912 |
| Change in Power of Attorney (May Include Associate POA) Critical | 10 Sep, 2018 | US8372872 |
| Email Notification Critical | 10 Sep, 2018 | US8372872 |
| Correspondence Address Change Critical | 07 Sep, 2018 | US8372872 |
Febuxostat's Family Patents
Explore Our Curated Drug Screens
Febuxostat Generics
Several generic applications have been filed for Febuxostat. The first generic version for Febuxostat was by Sun Pharmaceutical Industries Ltd and was approved on Jul 1, 2019. And the latest generic version is by Lupin Ltd and was approved on Jan 17, 2024.
Given below is the list of companies who have filed for Febuxostat generic.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Jul 1, 2019 |
| 80MG | tablet | Prescription | ORAL | AB | Jul 1, 2019 |
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Dec 7, 2021 |
| 80MG | tablet | Prescription | ORAL | AB | Dec 7, 2021 |
3. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Oct 25, 2023 |
| 80MG | tablet | Prescription | ORAL | AB | Oct 25, 2023 |
4. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 80MG | tablet | Prescription | ORAL | AB | Oct 22, 2020 |
| 40MG | tablet | Prescription | ORAL | AB | Oct 22, 2020 |
5. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Oct 15, 2019 |
| 80MG | tablet | Prescription | ORAL | AB | Oct 15, 2019 |
6. INDOCO
Indoco Remedies Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Indoco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Dec 30, 2019 |
| 80MG | tablet | Prescription | ORAL | AB | Dec 30, 2019 |
7. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Discontinued | ORAL | N/A | Jan 17, 2024 |
| 80MG | tablet | Discontinued | ORAL | N/A | Jan 17, 2024 |
8. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Sep 28, 2023 |
| 80MG | tablet | Prescription | ORAL | AB | Sep 28, 2023 |
9. MSN
Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 80MG | tablet | Prescription | ORAL | BX | Dec 30, 2019 |
| 40MG | tablet | Prescription | ORAL | BX | Dec 30, 2019 |
10. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2019 |
| 80MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2019 |
11. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Mar 28, 2022 |
| 80MG | tablet | Prescription | ORAL | AB | Mar 28, 2022 |
12. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | tablet | Prescription | ORAL | AB | Jul 1, 2019 |
| 80MG | tablet | Prescription | ORAL | AB | Jul 1, 2019 |
13. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 80MG | tablet | Prescription | ORAL | AB | Jun 2, 2020 |
| 40MG | tablet | Prescription | ORAL | AB | Jun 2, 2020 |
14. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 80MG | tablet | Discontinued | ORAL | N/A | Dec 19, 2023 |
| 40MG | tablet | Discontinued | ORAL | N/A | Dec 19, 2023 |
15. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 2 different strengths of generic version for Febuxostat. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 80MG | tablet | Prescription | ORAL | AB | Jan 9, 2023 |
| 40MG | tablet | Prescription | ORAL | AB | Jan 9, 2023 |